11.54
前日終値:
$11.05
開ける:
$11.02
24時間の取引高:
1.95M
Relative Volume:
0.97
時価総額:
$967.13M
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-3.8986
EPS:
-2.96
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
+9.70%
1か月 パフォーマンス:
-11.50%
6か月 パフォーマンス:
-41.98%
1年 パフォーマンス:
-44.36%
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
名前
Syndax Pharmaceuticals Inc
セクター
電話
781-419-1400
住所
35 GATEHOUSE DRIVE, WALTHAM, MA
SNDX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SNDX
Syndax Pharmaceuticals Inc
|
11.54 | 967.13M | 139.71M | -209.36M | -160.60M | -2.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-10-24 | 開始されました | UBS | Buy |
2024-06-28 | 開始されました | Jefferies | Buy |
2024-01-31 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
2023-12-22 | 開始されました | Mizuho | Buy |
2023-10-25 | 開始されました | BofA Securities | Buy |
2023-10-11 | 開始されました | Goldman | Buy |
2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
2023-07-11 | 開始されました | Guggenheim | Buy |
2023-04-17 | 再開されました | BTIG Research | Buy |
2023-01-31 | 開始されました | Stifel | Buy |
2023-01-03 | 開始されました | JP Morgan | Overweight |
2022-07-28 | 再開されました | B. Riley Securities | Buy |
2022-04-11 | 開始されました | H.C. Wainwright | Buy |
2022-02-15 | 開始されました | Goldman | Buy |
2021-06-04 | 再開されました | Robert W. Baird | Outperform |
2021-05-25 | 開始されました | Citigroup | Buy |
2021-02-18 | 開始されました | B. Riley Securities | Buy |
2020-12-03 | 開始されました | Stifel | Buy |
2020-05-22 | アップグレード | Citigroup | Neutral → Buy |
2020-05-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-05-18 | ダウングレード | Citigroup | Buy → Neutral |
2020-05-11 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-04 | 開始されました | Barclays | Overweight |
2020-01-13 | 繰り返されました | H.C. Wainwright | Buy |
2019-03-08 | 繰り返されました | H.C. Wainwright | Buy |
2019-01-04 | 開始されました | Robert W. Baird | Outperform |
2018-01-05 | 開始されました | B. Riley FBR, Inc. | Buy |
2017-03-16 | 開始されました | FBR & Co. | Outperform |
2017-03-02 | 開始されました | Instinet | Buy |
2016-10-07 | 開始されました | Guggenheim | Buy |
2016-03-28 | 開始されました | Citigroup | Buy |
2016-03-28 | 開始されました | JMP Securities | Mkt Outperform |
2016-03-28 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Syndax Pharmaceuticals Inc (SNDX) 最新ニュース
Walleye Capital LLC Has $4.82 Million Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
(SNDX) On The My Stocks Page - news.stocktradersdaily.com
Sei Investments Co. Lowers Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
StockNews.com Upgrades Syndax Pharmaceuticals (NASDAQ:SNDX) to "Sell" - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by ExodusPoint Capital Management LP - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 6.6%Time to Sell? - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week LowHere's Why - MarketBeat
Sei Investments Co. Sells 35,414 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Barclays Adjusts Price Target for Syndax (SNDX) Ahead of Q1 Earnings | SNDX Stock News - GuruFocus
Vanguard Group Inc. Sells 5,006 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Rhenman & Partners Asset Management AB - MarketBeat
Trexquant Investment LP Buys 437,859 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Bryce Point Capital LLC Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to “Sell” at StockNews.com - Defense World
SNDX stock touches 52-week low at $10.14 amid market challenges By Investing.com - Investing.com South Africa
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Wellington Management Group LLP - MarketBeat
Syndax at Stifel Forum: Strategic Drug Launches By Investing.com - Investing.com Canada
Corebridge Financial Inc. Has $540,000 Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX) - Seeking Alpha
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 4.7% HigherStill a Buy? - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Sell at StockNews.com - MarketBeat
Axiom Investors LLC DE Sells 62,418 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 12-Month LowWhat's Next? - MarketBeat
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.5%Should You Sell? - MarketBeat
How the (SNDX) price action is used to our Advantage - news.stocktradersdaily.com
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum - GlobeNewswire
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Teacher Retirement System of Texas - Defense World
Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to Sell at StockNews.com - Defense World
Syndax Pharmaceuticals Inc (SNDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):